Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete Adherence

NCT00215579 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT00215579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00215579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete Adherence
Lead sponsor
Duke University
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2004
Completion date
April 30, 2006
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia